celltherapynews.com


Tags Whois Backlink & Rankings Speed Safety Headers Similar Sites Keywords H Tags
Tags Whois Rank Speed Safety Headers Similar Sites Keywords H Tags

celltherapynews.com Website Info

celltherapynews.com (CellTherapyNews.com is a dedicated platform providing the latest updates, research insights, and news in the field of cell therapy and regenerative medicine, helping professionals and enthusiasts stay informed about advancements and clinical developments.) was registered first at 2001-07-30 22:31:57. DNS looks Active and website looks Accessable. Domain Moz Rank is 3.1. According to Google, website speed score is 70/100 and AVERAGE. Website looks safe for children. We detected the website language as en-US.
celltherapynews.com


celltherapynews.com Website Tags

Domain Status:
✓ Active
Is Site Accessable?:
✓ Yes
SSL(https):
✓ Yes
Accessable Url:
https://www.celltherapynews.com
Title:
Cell Therapy News | Latest Advances in Regenerative Medicine
Description:
Cell Therapy News is an online resource dedicated to sharing the latest cell therapy, gene therapy, and regenerative medicine research.
Categories :
Business, Health and Wellness
External Links:
136
Internal Links:
12
Canonical URL:
[Not Set]
Language:
en-US
XML Sitemap:
✗ No
robots.txt:
✗ No
Favicon:
✓ Yes

celltherapynews.com Domain & Whois Details

Refresh
Domain Create Date:
2001-07-30 22:31:57
Domain Age:
23 years, 11 months, 5 days
Domain Expire Date:
2023-07-30T22:31:53Z
Domain Last Update Date:
2023-07-30T22:31:53Z
Domain Owner:
http://www.godaddy.com - GoDaddy.com, LLC -
Server Software:
WP Engine
Server Type:
nginx
Nameservers:
CLAY.NS.CLOUDFLARE.COM - KRISTIN.NS.CLOUDFLARE.COM -
Hosting Location:
Country:United States, City:New York, Isp:Cloudflare, Inc., Org:Cloudflare, Inc.
IP:
104.21.70.178 , 172.67.138.40

celltherapynews.com Backlinks & Rankings

Moz Rank:
3.1
MozRank is developed by SEOmoz similar to Google Pagerank and scaled 10-point measurement.
Moz DA:
27
Moz Domain Authority (DA) is a search engine ranking score developed by Moz that predicts how well a website will rank on search engine result pages. Domain Authority scores range from one to 100, with higher scores corresponding to greater likelihood of ranking.
Moz PA:
31
Moz Page Authority (PA) is Page Authority (PA) is a score developed by Moz that predicts how well a specific page will rank on search engine result pages (SERP). Page Authority scores range from one to 100, with higher scores corresponding to a greater ability to rank.
MOZ Total Links:
67
Number of total links (equity or nonequity or not, internal or external) to the URL.
MOZ External Links:
35
Number of external equity links to the URL.
SEMRush URL Links:
56
Number of links to URL according to SemRush.
SEMRush Website Links:
81
Number of links to the website according to SemRush.
SEMRush Domain Links:
2,967
Number of links to SemRush Domain.

celltherapynews.com Social Media

Facebook Comments:
9
Facebook Shares:
226
Facebook Reactions:
31

celltherapynews.com Website Speed (Desktop)

Refresh
Overall Category:
AVERAGE
The human readable speed "category"
Speed Index:
70
Speed Index shows how quickly the contents of a page are visibly populated. [Learn more about the Speed Index metric].
Cumulative Layout Shift (CLS):
0.03 (FAST)
The Cumulative Layout Shift (CLS) metric measures how much unexpected layout shifts affect the user experience on a page. These layout shifts occur when content moves around without prior user input. CLS
Time to First Byte (TTFB):
1.485 s (AVERAGE)
TTFB (time to first byte) is the number of milliseconds it takes for a client’s browser to receive the first byte of the response from the web server. Usually, TTFB can be improved with faster hosting and server optimizations. TTFB
First Input Delay (FID):
3 ms (FAST)
First Input Delay (FID) measures the time from when the user interacts with your site for the first time (click a link, tap on a button, etc.) to the time when the browser is able to respond to that interaction. Google recommends keeping FID below 100ms for a good user experience. FID
First Contentful Paint (FCP):
2.237 s (AVERAGE)
FCP (First Contentful Paint) measures the time from a user’s navigation to when the browser renders the first bit of content from the DOM. In other words, FCP marks the time at which the first text or image is painted for the user. According to PageSpeed Insights, FCP should occur in under 2 seconds. FCP
Interaction to Next Paint (INP):
40 ms (FAST)
Interaction to Next Paint (INP) is a web performance metric that measures user interface responsiveness – how quickly a website responds to user interactions like clicks or key presses. Specifically, it measures how much time elapses between a user interaction like a click or key press and the next time the user sees a visual update on the page. INP
Largest Contentful Paint (LCP):
2.624 s (AVERAGE)
Largest Contentful Paint (LCP) is a metric that measures when the largest content in the viewport is rendered. It is used to measure how long it takes for the main content of your webpage to appear on the screen. Everything below 2.5s is considered good LCP time by PageSpeed Insights. LCP
Total Size:
1464 KB
Total Size. Large network payloads cost users real money and are highly correlated with long load times.
Server Response Time:
422 ms
Initial server response time. Keep the server response time for the main document short because all other requests depend on it. [Learn more about the Time to First Byte metric](https://developer.chrome.com/docs/lighthouse/performance/time-to-first-byte/).
Final Url:
https://www.stemcellsciencenews.com/cell-therapy-news/
Canonicalized and final URL for the document, after following page redirects (if any).
Last Date Checked:
7/1/2023 2:38:49 PM
The last time we checked this website.
Site Speed Check(Full)

celltherapynews.com HTML Resources

Type
Request Count
Size
Total
86
1,464 KB
Third-party
84
1,401 KB
Script
21
470 KB
Font
10
402 KB
Image
30
339 KB
Stylesheet
17
177 KB
Document
1
51 KB
Other
7
22 KB
Media
0
0 KB

celltherapynews.com Website Safety

Refresh
Last Check Date:
2/27/2023 6:49:53 AM
Fortiguard:
Health and Wellness
Mcafee Category:
Business
OpenDNS:
BeFirst
Cloudflare DNS:
OK
MyWot Child Safety:
99

celltherapynews.com HTTP Headers

Refresh
Accept-Ranges :
bytes
Cache-Control :
max-age=600, must-revalidate
Connection :
keep-alive
Content-Length :
391435
Content-Security-Policy :
upgrade-insecure-requests
Content-Type :
text/html; charset=UTF-8
Date :
Thu, 08 Jun 2023 15:00:16 GMT
Keep-Alive :
timeout=20
Link :
<https://www.stemcellsciencenews.com/wp-json/>; rel="https://api.w.org/",<https://www.stemcellscienc
Server :
nginx
Vary :
Accept-Encoding,Accept-Encoding,Accept-Encoding,Accept-Encoding,Cookie
X-Cache :
HIT: 2
x-cacheable :
SHORT
x-cache-group :
normal
X-Powered-By :
WP Engine
x-tec-api-origin :
https://www.stemcellsciencenews.com
x-tec-api-root :
https://www.stemcellsciencenews.com/wp-json/tribe/events/v1/
x-tec-api-version :
v1


celltherapynews.com W3C HTML Validation Check Now

Last Check Date:
5/31/2023 12:00:00 AM
Errors:
184
Warnings:
0
Info:
23
Check Live:
Check celltherapynews.com HTML Errors

celltherapynews.com Similar Sites

Website
Title
Rank
stemcell.com stemcell.com
StemCell.com - Advanced Stem Cell Research & Therapy
59,843
onlinewellnesscommunity.com onlinewellnesscommunity.com
Online Wellness Community | Connect, Share & Grow
45,826,681
ipscell.com ipscell.com
Stem Cell Blog & Resources | Paul Knoepfler UC Davis - The Niche
167,008
ifats.org ifats.org
IFATS - International Federation for Adipose Therapeutics and Science
stemcellsportal.com stemcellsportal.com
Stem Cells Portal | The Stem Cells and Regenerative Medicine Online Community
4,947,117
Top celltherapynews.com Alternatives

celltherapynews.com Site Keywords

and regenerative medicine research
biomedical research
Cell therapy
cell therapy news
clinical trials
gene therapy
regenerative medicine
Science News
Stem Cells

celltherapynews.com Site H Tags

Check Now
h1
Cell Therapy News
h3
Unrelated or Haploidentical Allogeneic Hematopoietic Cell Transplantation in Second Complete Remissi
h3
US DoD Funds Stem Cell Research for Severe Traumatic Brain Injury
h3
‘It’s a Vote for Hope’: First Gene Therapy for Muscular Dystrophy Nears Approval, but Will It Work?
h3
Dual Human iPSC-Derived Cardiac Lineage Cell-Seeding Extracellular Matrix Patches Promote Regenerati
h3
Exploratory Study on the Efficacy of Bortezomib Combining Mitoxantrone or CD22-CAR T Therapy Targeti
h3
A Novel Autologous CAR-T Therapy, YTB323, With Preserved T-Cell Stemness Shows Enhanced CAR T-Cell E
h3
Lysophosphatidic Acid Modulates CD8 T Cell Immunosurveillance and Metabolism To Impair Anti-Tumor Im
h3
Developing Hypoimmunogenic Human iPSC-Derived Oligodendrocyte Progenitor Cells as an Off-the-Shelf C
h3
Unrelated or Haploidentical Allogeneic Hematopoietic Cell Transplantation in Second Complete Remissi
h3
Activation-Inducible CAR Expression Enables Precise Control Over Engineered CAR T Cell Function
h3
Efficient Chimeric Antigen Receptor (CAR) Targeting of a Central Epitope of CD22
h3
Nanocarriers for Photodynamic-Gene Therapy


What is SitesDB?

SitesDB is one of the largest databases of websites and domain names on the internet, with over 40 million entries and growing. For more than 12 years, we've been manually verifying and updating website and domain details, combining human expertise with AI-powered systems to ensure the accuracy and relevance of our data.

At SitesDB, we provide in-depth technical and useful information about websites and domains, including:

  • Website meta tags
  • Domain & WHOIS data
  • General backlink and ranking statistics
  • Social media engagement stats
  • Root page speed insights
  • Website content and HTML resources
  • Website safety and security details, sourced from multiple trusted security providers
  • HTTP headers analysis
  • HTML validation reports
  • Lists of similar websites and competitors
  • Website keyword analysis, including top traffic-driving keywords
  • Heading structure (H tags) breakdown
  • Domain variations across different TLDs (Top-Level Domains)

In addition to this data, SitesDB offers a suite of website analysis tools — including Chrome CRUX, Google Lighthouse, and our own AI-enhanced algorithms — to help identify alternative websites, direct competitors, and similar sites, all continuously refined through both automated systems and human review.